Erbitux: fighting secondary liver cancer with antibodies

Jim’s son is now getting better thanks to his holistic cancer treatments and Erbitux. Erbitux isn’t chemotherapy but in stead are antibodies helping your body to fight the cancer.

Pretty logical approach to cure cancer:

• not using a poisonous chemotherapy in the hope to kill the cancer without killing the person buy
• making sure your body has an extra advantage in fighting the cancer by "adding antibodies".

What is Erbitux?

Erbitux is a mouse/human monoclonal antibody – monoclonal meaning all of them are cloned or made originating from the same cell.

It is an epidermal growth factor receptor inhibitor and given by intravenous infusion for treatment of metastatic colorectal cancer and Erbitux is also known to treat head and neck cancer. Jim’s son is now taking it in how to beat metastatic liver cancer.

Why is Erbitux so expensive?

Making Erbitux in a laboratory is more or less as expensive as developing chemotherapy drugs. However, one month of Erbitux treatment costs about $17,000 a month. (Avastin, an other monoclonal antibody costs about 4 times ‘less’). This means that only the rich few and the ones that have a decent cancer health insurance have access to Erbitux. Is this a sad and financially sick way to keep poisonous chemotherapy on the market as long as possible and make "easy money" from something that has already been tested, researched and unfortunately never managed to become a miracle cure?

For now, let’s focus on Jim’s son battling his secondary liver cancer, and keep our fingers crossed he will get better each and every day to inspire the rest of us and cancer researcher all over the world.

Thanks Jim for updating us, hugs and lots of good health for you, your family and your loved ones.